ConductScience.org, home

Paper911652

Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.

Scanlon MF and 8 others. Br J Clin Pharmacol, 1977. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man. Papers, record 911652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/911652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2019-05-09
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scanlon MFM F
2Gomez-Pan AA
3Mora BB
4Cook DBD B
5Dewar JHJ H
6Hildyard AA
7Weightman DRD R
8Evered DCD C
9Hall RR

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcromegalyMajor topic
IsoquinolinesMajor topic
NomifensineMajor topic
ProlactinMajor topic
Adult
Female
Humans
Male
Tyrosine

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14441422Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.Biochem Pharmacol1974https://conductscience.org/library/papers/4441422PubMed
24434467Estrogen-induced transformation of somatotrophs into mammotrophs in the rat.Cell Tissue Res1974https://conductscience.org/library/papers/4434467PubMed
34823928Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.J Clin Endocrinol Metab1974https://conductscience.org/library/papers/4823928PubMed
414204536IMMUNOASSAY OF SERUM GROWTH HORMONE IN ACROMEGALIC PATIENTS.Br Med J1964https://conductscience.org/library/papers/14204536PubMed
55107027Levodopa suppression of prolactin in nonpuerperal galactorrhea.N Engl J Med1971https://conductscience.org/library/papers/5107027PubMed
64375258Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.Naunyn Schmiedebergs Arch Pharmacol1974https://conductscience.org/library/papers/4375258PubMed
74153459Rapid induction of prolactin secretion by 3-iodo-L-tyrosine.Neuroendocrinology1974https://conductscience.org/library/papers/4153459PubMed
84152974Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.J Pharm Pharmacol1974https://conductscience.org/library/papers/4152974PubMed
94351250Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.Schweiz Med Wochenschr1973https://conductscience.org/library/papers/4351250PubMed
104254791Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.Endocrinology1971https://conductscience.org/library/papers/4254791PubMed
114213193Interaction of thyrotropin-releasing hormone and dopamine on the release of prolactin from the rat anterior pituitary in vitro.Endocrinology1974https://conductscience.org/library/papers/4213193PubMed
124214694Effect of catecholamines on the TRH-stimulated release of prolactin and growth hormone from sheep pituitaries in vitro.Endocrinology1974https://conductscience.org/library/papers/4214694PubMed
134214834Evidence for a direct effect of thyrotropin-releasing hormone (TRH) on prolactin release in humans.J Clin Endocrinol Metab1974https://conductscience.org/library/papers/4214834PubMed
144624348L-DOPA suppression of thyrotropin-releasing hormone response in man.J Clin Endocrinol Metab1972https://conductscience.org/library/papers/4624348PubMed
154196264L-dopa suppression of TRH-stimulated prolactin release in man.J Clin Endocrinol Metab1973https://conductscience.org/library/papers/4196264PubMed
164196262Prolactin response to thyrotropin releasing hormone in normal subjects.J Clin Endocrinol Metab1973https://conductscience.org/library/papers/4196262PubMed
174600507Modulation of pituitary responsiveness to LRF by estrogen.J Clin Endocrinol Metab1974https://conductscience.org/library/papers/4600507PubMed
184600593Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.Br Med J1974https://conductscience.org/library/papers/4600593PubMed
194753435Estrogen potentiation of phenothiazine-induced prolactin secretion in man.J Clin Endocrinol Metab1973https://conductscience.org/library/papers/4753435PubMed
204672297The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).J Clin Endocrinol Metab1972https://conductscience.org/library/papers/4672297PubMed

See all 31 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
6408155Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.J Endocrinol Invest1983https://conductscience.org/library/papers/6408155PubMed
6133737Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.Drugs1983https://conductscience.org/library/papers/6133737PubMed
6104974Neuroendocrine markers of CNS drug effects.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6104974PubMed
3063922Drug-induced changes in prolactin secretion. Clinical implications.Med Toxicol Adverse Drug Exp1988https://conductscience.org/library/papers/3063922PubMed
231066Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.J Endocrinol Invest1979https://conductscience.org/library/papers/231066PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene
TRH7200PubTator's text mininghttps://conductscience.org/library/genes/7200NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/911652

GET https://conductscience.org/api/papers/v1/911652/references?page=2